Detalhe da pesquisa
1.
Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents - SMART 2018-2021.
J Formos Med Assoc
; 123(3): 400-407, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735013
2.
In Vitro Activity of Ceftibuten-Avibactam against ß-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program.
Antimicrob Agents Chemother
; 67(1): e0134622, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602322
3.
In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program.
Antimicrob Agents Chemother
; 67(1): e0128122, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541767
4.
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i17-i25, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130586
5.
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i8-i16, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130584
6.
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
J Antimicrob Chemother
; 78(Suppl 1): i37-i47, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130588
7.
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
J Antimicrob Chemother
; 78(Suppl 1): i26-i36, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130587
8.
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021.
Eur J Clin Microbiol Infect Dis
; 42(9): 1135-1143, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526796
9.
In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021.
Antimicrob Agents Chemother
; 66(9): e0078122, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005804
10.
In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
Antimicrob Agents Chemother
; 66(1): e0130421, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662183
11.
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-ß-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection.
Antimicrob Agents Chemother
; 66(11): e0093422, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286518
12.
In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019.
Antimicrob Agents Chemother
; 66(2): e0199021, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807757
13.
In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes.
Antimicrob Agents Chemother
; 66(2): e0216521, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930028
14.
In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020.
Antimicrob Agents Chemother
; 66(5): e0018922, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491836
15.
Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens.
J Clin Microbiol
; 60(4): e0253021, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317619
16.
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
J Antimicrob Chemother
; 77(11): 3035-3038, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971759
17.
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
J Antimicrob Chemother
; 77(5): 1444-1451, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141750
18.
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
J Antimicrob Chemother
; 77(12): 3414-3420, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177825
19.
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017.
Clin Infect Dis
; 72(12): 2112-2120, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32246147
20.
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017.
Antimicrob Agents Chemother
; 65(7): e0200020, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972241